Dong-A ST Wins Korean Approval for Sugar Mpa Combination Drug
Dong-A ST received South Korean regulatory approval on Oct. 30, 2026, for Sugar Mpa, a combination drug for type 2 diabetes.
Dong-A ST received South Korean regulatory approval on Oct. 30, 2026, for Sugar Mpa, a combination drug for type 2 diabetes.